Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Guardant Health, Inc. - Common Stock (NQ:GH)

101.50 -1.48 (-1.44%)

Streaming Delayed Price Updated: 3:08 PM EST, Dec 29, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	374,455
Open	102.52
Bid (Size)	101.45 (100)
Ask (Size)	101.55 (200)
Prev. Close	102.98
Today's Range	101.11 - 103.21
52wk Range	29.91 - 112.42
Shares Outstanding	101,298,669
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why a Top Biotech Holder Sold 115,000 Mirum Shares but Still Ended Up With $185 Million on the Line ↗

December 28, 2025

Selling shares usually signals doubt, but in this case the math points to something very different happening beneath the surface.

Via The Motley Fool

Q3 Earnings Roundup: Cardinal Health (NYSE:CAH) And The Rest Of The Healthcare Providers & Services Segment

December 17, 2025

Looking back on healthcare providers & services stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Cardinal Health (NYSE:CAH) and its peers.

Via StockStory

Performance

YTD	+219.5%	+219.5%
1 Month	-6.4%	-6.4%
3 Month	+63.7%	+63.7%
6 Month	+95.0%	+95.0%
1 Year	+232.4%	+232.4%

More News

Q3 Rundown: The Ensign Group (NASDAQ:ENSG) Vs Other Healthcare Providers & Services Stocks

December 15, 2025

Via StockStory

Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S.

December 11, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy

December 09, 2025

From Guardant Health, Inc.

Via Business Wire

3 Volatile Stocks Walking a Fine Line

December 07, 2025

Via StockStory

Guardant Health to Present 14 Abstracts Demonstrating the Power of Multiomic Liquid Biopsy Tests in Predicting Outcomes and Tailoring Treatment for Early and Metastatic Breast Cancer at the 2025 San Antonio Breast Cancer Symposium

December 05, 2025

From Guardant Health, Inc.

Via Business Wire

Why Guardant Health (GH) Stock Is Up Today

December 03, 2025

Via StockStory

Healthcare Providers & Services Stocks Q3 Recap: Benchmarking AMN Healthcare Services (NYSE:AMN)

December 01, 2025

Via StockStory

Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know

November 24, 2025

Via StockStory

Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings?

November 23, 2025

Via StockStory

Healthcare Providers & Services Stocks Q3 In Review: Pediatrix Medical Group (NYSE:MD) Vs Peers

November 23, 2025

Via StockStory

Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know

November 21, 2025

Via StockStory

Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗

November 20, 2025

Via Benzinga

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

3 Mid-Cap Stocks That Concern Us

November 13, 2025

Via StockStory

Guardant Health Announces Launch of Single Namespace Group Uniting Leading Technology, Healthcare and Research Institutions to Set Global Standard for Exabyte-Scale Data Access

November 12, 2025

From Guardant Health, Inc.

Via Business Wire

Healthcare Providers & Services Stocks Q3 In Review: McKesson (NYSE:MCK) Vs Peers

November 11, 2025

Via StockStory

Guardant Health Expands Tissue-Free Reveal Test to Include Late-Stage Therapy Response Monitoring

November 10, 2025

From Guardant Health, Inc.

Via Business Wire

Guardant Health to Participate in Upcoming Investor Conferences

November 07, 2025

From Guardant Health, Inc.

Via Business Wire

1 Growth Stock with All-Star Potential and 2 That Underwhelm

November 06, 2025

Via StockStory

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 06, 2025

From Guardant Health, Inc.

Via Business Wire

New Study Validates Guardant Reveal Blood Test’s Effectiveness in Monitoring Chemotherapy Response

November 06, 2025

From Guardant Health, Inc.

Via Business Wire

Stocks making big moves yesterday: Clover Health, Rivian, Johnson Controls, Kratos, and Guardant Health

November 06, 2025

Via StockStory

Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients

November 05, 2025

From Guardant Health, Inc.

Via Business Wire

Frequently Asked Questions

Is Guardant Health, Inc. - Common Stock publicly traded?

Yes, Guardant Health, Inc. - Common Stock is publicly traded.

What exchange does Guardant Health, Inc. - Common Stock trade on?

Guardant Health, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Guardant Health, Inc. - Common Stock?

The ticker symbol for Guardant Health, Inc. - Common Stock is GH on the Nasdaq Stock Market

What is the current price of Guardant Health, Inc. - Common Stock?

The current price of Guardant Health, Inc. - Common Stock is 101.50

When was Guardant Health, Inc. - Common Stock last traded?

The last trade of Guardant Health, Inc. - Common Stock was at 12/29/25 03:08 PM ET

What is the market capitalization of Guardant Health, Inc. - Common Stock?

The market capitalization of Guardant Health, Inc. - Common Stock is 10.28B

How many shares of Guardant Health, Inc. - Common Stock are outstanding?

Guardant Health, Inc. - Common Stock has 10B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.